JFL Life Sciences Ltd - JFL LIFE Share Price

Sector: Pharmaceuticals | ISIN: INE0LA901015
₹ 47.20 (2.72%) icon21 Feb, 2024, 9:56:54 AM

JFL Life Sciences Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/21/2024 9:56:54 AM

    ₹ 47.2 1.25 2.72
  • Open
  • ₹ 46.5
  • Prev. Close
  • ₹ 45.95
  • Turnover(Lac.)
  • ₹ 2
  • Day's High
  • ₹ 47.2
  • Day's Low
  • ₹ 46.5
  • 52 Week's High
  • ₹ 56
  • 52 Week's Low
  • ₹ 32.15
  • Book Value
  • ₹ 0
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 51.91
  • P/E
  • 18.02
  • EPS
  • 2.55
  • Divi. Yield
  • 0

JFL Life Sciences Ltd Corporate Actions

31 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Sep , 2023

12:00 AM

AGM

Announcement date: 01 Sep , 2023

View Details

19 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

16 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

JFL Life Sciences Ltd News and Update

Image not found
  • 16 February, 2024 |
  • 11:58 PM

Next hearing scheduled for March 13.

Image not found
  • IIFL News Service |
  • 16 February, 2024 |
  • 11:57 PM
Image not found
Image not found
  • IIFL News Service |
  • 15 February, 2024 |
  • 11:56 PM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

JFL Life Sciences Ltd SHAREHOLDING SNAPSHOT
21 February , 2024 | 10:19 AM

PROMOTER - TOTAL67.47%

Indian: 67.47%

Foreign: 0%

NON-PROMOTER - TOTAL 32.53%

Institutions: 0.00%

Non-Institutions: 32.53%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

JFL Life Sciences Ltd FINANCIALS

No Data Available To Display Chart

JFL Life Sciences Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT JFL Life Sciences Ltd

  • Smiral Ashwinkumar Patel
  • Managing Director
  • Manishkumar Jasvantlal Patel
  • Chairman & Non Executive Dir.
  • Tejal Smiral Patel
  • Whole-time Director
  • Sonu Lalitkumar Jain
  • Non-Exec. & Independent Dir.
  • Bhavna Shah
  • Non-Exec. & Independent Dir.
  • Pratima Singh
  • Company Secretary

Summary

JFL Life Sciences Ltd. was incorporated as JFL Life Sciences Private Limited on April 25, 2010 as a Private Limited Company under Companies Act, 1956. Pursuant to a Special Resolution held on February 10, 2022, Company converted from a Private Limited to Public Limited Company and name of the Company was changed to JFL Life Sciences Limited, on March 3, 2022. The Company primarily manufactures and market pharmaceutical products. Its product portfolio consists of Dry powder injections, Tablets & Capsules (B-Lactam) solid oral dosage form, Tablet and Capsules (general) and Oral Rehydration Solutions (ORS). The Company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care, it has laid a strong R&D foundation and a FDA approved manufacturing facility near Ahmedabad. It also export products to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. For the purpose of identification equipment / machinery / containers are appropriately labelled to identify the stage of process. In case of tablets, the materials are quarantined after granulation, compression, coating and final packing operations for clearance from Q.A. before pursuing the next stage of process. In case of capsule, the materials are quarantined after mixing, filling and final... Read More


Reports by JFL Life Sciences Ltd


Reports by JFL Life Sciences Ltd

Company FAQ

No Record Found